Open Medicine

Side-effects reporting for drug trials + more

Submitted by Carlyn Zwarenstein on September 16, 2014 - 12:00

Over the years, Open Medicine authors have taken a strong interest in research ethics and particularly the dangers of overly-close or conflicted relationships with pharmaceutical and medical device companies. As you may have intuited from the "closed for submissions" notice on our home page, for a variety of reasons Open Medicine is going to be closing up shop over the next couple of months.

Welcome to OM blog

Submitted by Dean Giustini on April 18, 2007 - 19:33

Welcome to the Open Medicine (OM) blog - a new interactive information and discussion forum for readers of our Journal. Our blog is a place to visit, share and learn something new. Please tell your friends about us.